Pulmonary Hypertension Trial, Recruiting (NCT07272798)

Pulmonary Hypertension Trial, Recruiting NCT07272798 Sponsor: Damascus University Condition: Pulmonary Hypertension

Printed from Voxsanity (voxsanity.com.au) — NCT07272798 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Pulmonary Hypertension

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are having a surgical procedure called pulmonary thromboendarterectomy (a lung blood vessel surgery) for a condition known as CTEPH (a type of high blood pressure in the lungs caused by blood clots)
People who are able to read, understand, and complete a consent form and study questionnaires

Who may not be able to join:

People who are having a different procedure called Balloon Pulmonary Angioplasty (BPA), or who are being treated with medication only rather than surgery
People whose surgery is being performed as an emergency or urgent life-saving procedure
People who are unable to complete questionnaires due to significant memory or thinking difficulties, a serious psychiatric condition, or a language barrier

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 21 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mohammad B Izzat, FRCS(CTh), Damascus University School of Medicine

Phone: +963948376770

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07272798

Sponsor: Damascus University

Phase: Not Applicable

Status: Recruiting

Condition: Pulmonary Hypertension

Trial contact: +963948376770

More information: https://clinicaltrials.gov/study/NCT07272798

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are having a surgical procedure called pulmonary thromboendarterectomy (a lung blood vessel surgery) for a condition known as CTEPH (a type of high blood pressure in the lungs caused by blood clots)
People who are able to read, understand, and complete a consent form and study questionnaires

Who may not be able to join:

People who are having a different procedure called Balloon Pulmonary Angioplasty (BPA), or who are being treated with medication only rather than surgery
People whose surgery is being performed as an emergency or urgent life-saving procedure
People who are unable to complete questionnaires due to significant memory or thinking difficulties, a serious psychiatric condition, or a language barrier

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 21 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Damascus University

Registry

ClinicalTrials.gov

Start date

20 November 2025

Est. completion

20 November 2026

Where this trial is recruiting

Syria

Primary endpoints

10-item Perceived Efficacy in Patient-Physician Interaction Scale (PEPPI); Self-Efficacy for Managing Chronic Diseases 6-item Scale (SEMCD-6); Sullivan's cardiac self-efficacy scale 13-items (SCSES); The 6-minute walk test (6MWT)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov